A detailed history of J.W. Cole Advisors, Inc. transactions in Haleon PLC stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 17,356 shares of HLN stock, worth $166,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,356
Previous 17,908 3.08%
Holding current value
$166,444
Previous $185,000 16.22%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$8.72 - $10.35 $4,813 - $5,713
-552 Reduced 3.08%
17,356 $155,000
Q2 2025

Aug 12, 2025

BUY
$9.27 - $11.41 $3,337 - $4,107
360 Added 2.05%
17,908 $185,000
Q1 2025

May 05, 2025

BUY
$9.02 - $10.67 $158,282 - $187,237
17,548 New
17,548 $180,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.